Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Gilead Sciences
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult (greater than or equal to 18 years) HIV-1 infected subjects regardless of race or ethnicity.
Subjects must be on a stable ARV regimen for greater than or equal to 1 month prior to study entry.
Evidence of protocol-defined Fanconi syndrome
TDF subjects must be on TDF-containing regimen at the time of onset of Fanconi syndrome.
Negative serum pregnancy test (females of child-bearing potential only).
Less than two years post-menopausal women of child-bearing potential (TDF subjects only) agree to follow an adequate birth control barrier method or agree to abstain from heterosexual intercourse while participating in the study.
The ability to understand and sign a written informed consent form, which must be obtained prior to initiation of any study procedures.
Adult (greater than or equal to 18 years) HIV-1 infected subjects regardless of race or ethnicity.
No evidence of protocol-defined Fanconi syndrome
On a TDF-containing regimen matched to a Fanconi case by clinic location, duration on TDF and age.
Negative serum pregnancy test (females of child-bearing potential only).
The ability to understand and sign a written informed consent form, which must be obtained prior to initiation of any study procedures.
You may not be if
Non TDF subjects who have received any TDF within the prior 6 months, or those who have received greater than 2 weeks cumulative treatment.
TDF subjects who have previously served as a TDF control for this protocol.
History of current alcohol or substance abuse judged by the investigator to potentially interfere with laboratory results.
History of current alcohol or substance abuse judged by the investigator to potentially interfere with laboratory results.
Clareo Health | Fanconi Syndrome Due to ARVs in HIV-Infected Persons
